{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:42:18Z","timestamp":1761990138434,"version":"build-2065373602"},"reference-count":33,"publisher":"Japanese Society of Internal Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.4763","type":"journal-article","created":{"date-parts":[[2015,12,31]],"date-time":"2015-12-31T17:10:31Z","timestamp":1451581831000},"page":"73-78","source":"Crossref","is-referenced-by-count":4,"title":["Emergence of Daptomycin-Resistant &lt;i&gt;Staphylococcus aureus&lt;\/i&gt; during Treatment"],"prefix":"10.2169","volume":"55","author":[{"given":"Hideharu","family":"Hagiya","sequence":"first","affiliation":[{"name":"Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuto","family":"Haruki","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Tsuyama Chuo Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taeko","family":"Uchida","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Graduate School of Clinical Pharmacy, Shujitsu University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Tsuyama Chuo Hospital, Japan"},{"name":"Department of Clinical Microbiology, Graduate School of Clinical Pharmacy, Shujitsu University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumiko","family":"Shiota","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Graduate School of Clinical Pharmacy, Shujitsu University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoharu","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Murase","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Microbiology Division, Tsuyama Chuo Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumio","family":"Otsuka","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Silverman JA, Perlmutter NG, Shapiro HM. Correlation of daptomycin bactericidal activity and membrane depolarization in <i>Staphylococcus aureus<\/i>. Antimicrob Agents Chemother 47: 2538-2544, 2003.","DOI":"10.1128\/AAC.47.8.2538-2544.2003"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant <i>Staphylococcus aureus<\/i> infections in adults and children. Clin Infect Dis 52: e18-e55, 2011.","DOI":"10.1093\/cid\/ciq146"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Fowler VG Jr, Boucher HW, Corey GR, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by <i>Staphylococcus aureus<\/i>. N Engl J Med 355: 653-665, 2006.","DOI":"10.1056\/NEJMoa053783"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Sakoulas G, Alder J, Thauvin-Eliopoulos C, et al. Induction of daptomycin heterogeneous susceptibility in <i>Staphylococcus aureus<\/i> by exposure to vancomycin. Antimicrob Agents Chemother 50: 1581-1585, 2006.","DOI":"10.1128\/AAC.50.4.1581-1585.2006"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Suzuki M, Tawada Y, Kato M, et al. Development of a rapid strain differentiation method for methicillin-resistant <i>Staphylococcus aureus<\/i> isolated in Japan by detecting phage-derived open-reading frames. J Appl Microbiol 101: 938-947, 2006.","DOI":"10.1111\/j.1365-2672.2006.02932.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Maeda T, Saga T, Miyazaki T, et al. Genotyping of skin and soft tissue infection (SSTI)-associated methicillin-resistant <i>Staphylococcus aureus<\/i> (MRSA) strains among outpatients in a teaching hospital in Japan: application of a phage-open reading frame typing (POT) kit. J Infect Chemother 18: 906-914, 2012.","DOI":"10.1007\/s10156-012-0506-4"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Peschel A, Otto M, Jack RW, et al. Inactivation of the dlt operon in <i>Staphylococcus aureus<\/i> confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem 274: 8405-8410, 1999.","DOI":"10.1074\/jbc.274.13.8405"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Humphries RM, Pollett S, Sakoulas G. A current perspective on daptomycin for the clinical microbiologist. Clin Microbiol Rev 26: 759-780, 2013.","DOI":"10.1128\/CMR.00030-13"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Mishra NN, Yang SJ, Sawa A, et al. Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant <i>Staphylococcus aureus<\/i>. Antimicrob Agents Chemother 53: 2312-2318, 2009.","DOI":"10.1128\/AAC.01682-08"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hayden MK, Rezai K, Hayes RA, et al. Development of Daptomycin resistance <i>in vivo<\/i> in methicillin-resistant <i>Staphylococcus aureus<\/i>. J Clin Microbiol 43: 5285-5287, 2005.","DOI":"10.1128\/JCM.43.10.5285-5287.2005"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Vikram HR, Havill NL, Koeth LM, et al. Clinical progression of methicillin-resistant <i>Staphylococcus aureus<\/i> vertebral osteomyelitis associated with reduced susceptibility to daptomycin. J Clin Microbiol 43: 5384-5387, 2005.","DOI":"10.1128\/JCM.43.10.5384-5387.2005"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sharma M, Riederer K, Chase P, et al. High rate of decreasing daptomycin susceptibility during the treatment of persistent <i>Staphylococcus aureus<\/i> bacteremia. Eur J Clin Microbiol Infect Dis 27: 433-437, 2008.","DOI":"10.1007\/s10096-007-0455-5"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Gasch O, Camoez M, Dominguez MA, et al. Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant <i>Staphylococcus aureus<\/i> persistent bacteraemia treated with daptomycin. J Antimicrob Chemother 69: 568-571, 2014.","DOI":"10.1093\/jac\/dkt396"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. van Hal SJ, Jensen SO, Vaska VL, et al. Predictors of mortality in <i>Staphylococcus aureus<\/i> Bacteremia. Clin Microbiol Rev 25: 362-386, 2012.","DOI":"10.1128\/CMR.05022-11"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Talbot GH, Bradley J, Edwards JE Jr, et al. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 42: 657-668, 2006.","DOI":"10.1086\/499819"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Cui L, Ma X, Sato K, et al. Cell wall thickening is a common feature of vancomycin resistance in <i>Staphylococcus aureus<\/i>. J Clin Microbiol 41: 5-14, 2003.","DOI":"10.1128\/JCM.41.1.5-14.2003"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Cui L, Tominaga E, Neoh HM, et al. Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate <i>Staphylococcus aureus<\/i>. Antimicrob Agents Chemother 50: 1079-1082, 2006.","DOI":"10.1128\/AAC.50.3.1079-1082.2006"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Yang SJ, Nast CC, Mishra NN, et al. Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in <i>Staphylococcus aureus<\/i>: evidence for multiple resistance mechanisms. Antimicrob Agents Chemother 54: 3079-3085, 2010.","DOI":"10.1128\/AAC.00122-10"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Bertsche U, Yang SJ, Kuehner D, et al. Increased cell wall teichoic acid production and D-alanylation are common phenotypes among daptomycin-resistant methicillin-resistant <i>Staphylococcus aureus<\/i> (MRSA) clinical isolates. PLoS One 8: e67398, 2013.","DOI":"10.1371\/journal.pone.0067398"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Friedman L, Alder JD, Silverman JA. Genetic changes that correlate with reduced susceptibility to daptomycin in <i>Staphylococcus aureus<\/i>. Antimicrob Agents Chemother 50: 2137-2145, 2006.","DOI":"10.1128\/AAC.00039-06"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Peleg AY, Miyakis S, Ward DV, et al. Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of <i>Staphylococcus aureus<\/i>. PLoS One 7: e28316, 2012.","DOI":"10.1371\/journal.pone.0028316"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Mishra NN, Bayer AS, Weidenmaier C, et al. Phenotypic and genotypic characterization of daptomycin-resistant methicillin-resistant <i>Staphylococcus aureus<\/i> strains: relative roles of mprF and dlt operons. PLoS One 9: e107426, 2014.","DOI":"10.1371\/journal.pone.0107426"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Sakoulas G, Rose W, Rybak MJ, et al. Evaluation of endocarditis caused by methicillin-susceptible <i>Staphylococcus aureus<\/i> developing nonsusceptibility to daptomycin. J Clin Microbiol 46: 220-224, 2008.","DOI":"10.1128\/JCM.00660-07"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Mwangi MM, Wu SW, Zhou Y, et al. Tracking the <i>in vivo<\/i> evolution of multidrug resistance in <i>Staphylococcus aureus<\/i> by whole-genome sequencing. Proc Natl Acad Sci U S A 104: 9451-9456, 2007.","DOI":"10.1073\/pnas.0609839104"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Pillai SK, Gold HS, Sakoulas G, et al. Daptomycin nonsusceptibility in <i>Staphylococcus aureus<\/i> with reduced vancomycin susceptibility is independent of alterations in MprF. Antimicrob Agents Chemother 51: 2223-2225, 2007.","DOI":"10.1128\/AAC.00202-07"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. van Hal SJ, Paterson DL, Gosbell IB. Emergence of daptomycin resistance following vancomycin-unresponsive <i>Staphylococcus aureus<\/i> bacteraemia in a daptomycin-naive patient--a review of the literature. Eur J Clin Microbiol Infect Dis 30: 603-610, 2011.","DOI":"10.1007\/s10096-010-1128-3"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Moise PA, North D, Steenbergen JN, et al. Susceptibility relationship between vancomycin and daptomycin in <i>Staphylococcus aureus<\/i>: facts and assumptions. Lancet Infect Dis 9: 617-624, 2009.","DOI":"10.1016\/S1473-3099(09)70200-2"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Sakoulas G, Eliopoulos GM, Alder J, et al. Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant <i>Staphylococcus aureus<\/i>. Antimicrob Agents Chemother 47: 1714-1718, 2003.","DOI":"10.1128\/AAC.47.5.1714-1718.2003"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Rose WE, Leonard SN, Rybak MJ. Evaluation of daptomycin pharmacodynamics and resistance at various dosage regimens against <i>Staphylococcus aureus<\/i> isolates with reduced susceptibilities to daptomycin in an <i>in vitro<\/i> pharmacodynamic model with simulated endocardial vegetations. Antimicrob Agents Chemother 52: 3061-3067, 2008.","DOI":"10.1128\/AAC.00102-08"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Vikram HR, Buenconsejo J, Hasbun R, et al. Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: a propensity analysis. JAMA 290: 3207-3214, 2003.","DOI":"10.1001\/jama.290.24.3207"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Bayer AS, Schneider T, Sahl HG. Mechanisms of daptomycin resistance in <i>Staphylococcus aureus<\/i>: role of the cell membrane and cell wall. Ann N Y Acad Sci 1277: 139-158, 2013.","DOI":"10.1111\/j.1749-6632.2012.06819.x"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Bobenchik AM, Hindler JA, Giltner CL, et al. Performance of Vitek 2 for antimicrobial susceptibility testing of <i>Staphylococcus spp<\/i>. and <i>Enterococcus spp<\/i>. J Clin Microbiol 52: 392-397, 2014.","DOI":"10.1128\/JCM.02432-13"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Barry AL, Fuchs PC, Brown SD. <i>In vitro<\/i> activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers. Antimicrob Agents Chemother 45: 1919-1922, 2001.","DOI":"10.1128\/AAC.45.6.1919-1922.2001"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/1\/55_55.4763\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T22:51:46Z","timestamp":1498258306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/1\/55_55.4763\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.4763","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2016]]}}}